Lenacapavir

invented by:

• Gilead Sciences

  Sources: Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women

Appears in1 item

• 
  HIV and AIDS1 item
  • Twice-yearly lenacapavir is approved for prevention18 Jun 2025

Sources

1. ArticleTwice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women
2. WebsiteWHO recommends injectable lenacapavir for HIV prevention